Treatment of metastatic cancer and model systems for metastatic disease

The present invention is further based, in part, on the discovery that L1CAM inhibition inhibited the growth of chemoresistant lung cancer xenografts, supporting a mechanism of action distinct from cytotoxic drugs, and that inhibition of L1CAM was observed to render chemoresistant tumor cells …